What is Mesa Laboratories, Inc.'s (MLAB) StockRank?

MoatMap's StockRank for Mesa Laboratories, Inc. (MLAB) is 74/100, with a Buy signal. This is a composite score combining Quality (51), Value (45), and Momentum (65) factor ranks across MoatMap's 20,000+ stock universe.

Does Mesa Laboratories, Inc. have an economic moat?

Mesa Laboratories, Inc. (MLAB) has a Quality factor score of 51/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Mesa Laboratories, Inc. a buy, hold, or sell?

MoatMap's current signal for Mesa Laboratories, Inc. (MLAB) is Buy, based on a StockRank of 74/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Mesa Laboratories, Inc. in?

Mesa Laboratories, Inc. (MLAB) operates in the Technology sector, specifically the Scientific & Technical Instruments industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

MLAB

BUYREMOVE

Mesa Laboratories, Inc. · Technology · United States · $570M · Avg Vol: $20M/d

StockRank

P/E (TTM)

87.2x

ROE

3.9%

D/E

0.9x

Dividend %

0.6%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Mesa Laboratories provides quality control instruments for life sciences. While historically a quality business, recent operational missteps, high debt from acquisitions, and integration issues have damaged its compounding thesis.

COMPANY DESCRIPTION

Mesa Laboratories, Inc. is a leading global developer, manufacturer, and marketer of quality control products and services, including sterility assurance, environmental monitoring, and medical device calibration. The company operates in highly regulated industries such as life sciences, healthcare, and industrial hygiene, where its precision instruments and consumables are critical for compliance and safety. Its specialized expertise and indispensable products create a strong competitive moat within these essential niche markets.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	184M	219M	216M	241M	9.3%
EPS	0.36	0.17	-47.20	-0.36	-52.8%
Shares	5M	5M	5M	5M	+3.6%
Debt	221M	186M	225M	181M	-6.4%
Equity	394M	393M	145M	160M	-26.0%
Op CF	39M	28M	44M	47M	6.1%
Inv CF	-305M	-9M	-81M	-4M	—
Fin CF	53M	-33M	33M	-45M	—

PRICE (1M)-10.4%

SMA 50SMA 200

$94.95

RSI (14)

39.3

52W High

$113.99

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

6.6%49.0

ROE

3.9%38.0

GP/Assets

36.5%77.6

Op. Margin

4.3%41.3

FCF/Assets

7.4%71.2

Piotroski

—79.5

Int. Cover

1.5x28.3

D/E Ratio

0.91x15.4

Current Ratio

1.72x40.8

Value

P/E (TTM)

87.2x22.7

EV/EBITDA

17.3x44.9

P/FCF

17.9x66.6

P/B

3.1x50.4

P/S

2.3x59.0

Div Yield

0.6%32.9

Momentum

52W High %

83%64.0

RS 6M

13%67.1

SMA 50/200

1.20x68.6

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+914%97.0

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$570M

P/E (Forward)

8.6x

Gross Margin

63.5%

SECTOR PEERS

Closest peers in Technology, ranked by industry match, size, and score similarity. Cross-listings of MLAB are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
MLAB	Mesa Laboratories, Inc.(you)	$570M	74	BUY
VPG	Vishay Precision Group, Inc.	$1.7B	60	HOLD
VNT	Vontier Corporation	$4.1B	71	BUY
ITRI	Itron, Inc.	$3.7B	66	BUY
IKE.AX	ikeGPS Group Limited	$136M	57	HOLD
ESE	ESCO Technologies Inc.	$7.9B	77	BUY
NOVT	Novanta Inc.	$5.7B	62	HOLD
BMI	Badger Meter, Inc.	$3.6B	51	HOLD
ST	Sensata Technologies Holding plc	$7.3B	86	STRONG BUY
CGNX	Cognex Corporation	$11.0B	85	STRONG BUY

Peer medians: ROE 9.0% · P/E 39.8x · Gross margin 54.7%

Mesa Laboratories, Inc. (MLAB) — Stock Score Summary

Mesa Laboratories, Inc. (MLAB) has a MoatMap StockRank of 74/100 based on Quality (51/100), Value (45/100), and Momentum (65/100) factor scores. The current signal is BUY. Mesa Laboratories provides quality control instruments for life sciences. While historically a quality business, recent operational missteps, high debt from acquisitions, and integration issues have damaged its compounding thesis.

Key Financial Metrics

Price	$94.95
Market Cap	$570M
P/E (TTM)	87.17
P/E (Forward)	8.60
Price/Book	3.12
Return on Equity	3.9%
Return on Invested Capital	6.6%
Debt/Equity	90.65
Gross Margin	63.5%
Operating Margin	4.3%
Revenue Growth	2.6%
Dividend Yield	0.6%
Free Cash Flow	$32M

Mesa Laboratories, Inc. operates in the Scientific & Technical Instruments industry, part of the Technology sector (United States).

Frequently Asked Questions

What is Mesa Laboratories, Inc.’s (MLAB) StockRank?: MoatMap’s StockRank for Mesa Laboratories, Inc. (MLAB) is 74/100, with a Buy signal. It is a composite of Quality (51), Value (45), and Momentum (65) factor ranks across MoatMap’s 20,000+ stock universe.
Does Mesa Laboratories, Inc. have an economic moat?: Mesa Laboratories, Inc. (MLAB) has a Quality factor score of 51/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Mesa Laboratories, Inc. a buy, hold, or sell?: MoatMap’s current signal for Mesa Laboratories, Inc. (MLAB) is Buy, based on a StockRank of 74/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Mesa Laboratories, Inc. in?: Mesa Laboratories, Inc. (MLAB) operates in the Technology sector, specifically the Scientific & Technical Instruments industry (United States).